ELEV Live signaler | Maksimer profitt med Getagraph.com

KJøP 116147 min ago

@ $2.71

Utstedt: 14 feb 2024 @ 16:56

Avkastning: 36.53%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: -6.62 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States...

Stats
Dagens volum	431 645
Gjennomsnittsvolum	1.03M
Markedsverdi	180.01M
EPS	$0 ( 2024-03-14 )
Neste inntjeningsdato	( $-0.210 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.76
ATR14	$0.00700 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-16	Ferra Joseph J Jr	Buy	12 562	Common Stock
2024-03-16	Ferra Joseph J Jr	Sell	4 773	Common Stock
2024-03-16	Ferra Joseph J Jr	Sell	12 562	Restricted Stock Unit
2024-02-29	Sandler Alan B.	Buy	55 000	Stock Option (Right to Buy)
2024-02-29	Cherrington Julie M	Buy	55 000	Stock Option (Right to Buy)

INSIDER POWER
76.38
Last 96 transactions
Buy: 15 904 291 \| Sell: 39 693 676

Volum Korrelasjon

Lang: -0.36 (neutral)

Kort: 0.85 (strong)

Signal:(23.66) Same movement expected

Elevation Oncology, Inc. Korrelasjon

10 Mest positive korrelasjoner
CRNT	0.959
KROS	0.954
TIOA	0.939
LVO	0.939
PRAX	0.937
DXJS	0.936
LPLA	0.934
COLL	0.933
PPH	0.931
MSDA	0.931

10 Mest negative korrelasjoner
DPRO	-0.938
SRNGW	-0.936
CRCT	-0.934
TBLT	-0.933
RIDE	-0.931
IMBI	-0.927
FFIE	-0.926
MSEX	-0.924
TCFC	-0.923
TENX	-0.922

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Elevation Oncology, Inc. Korrelasjon - Valuta/Råvare

-0.61
( weak negative )

-0.72
( moderate negative )

0.00
( neutral )

-0.78
( moderate negative )

-0.44
( neutral )

Elevation Oncology, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-39 000.00 (0.00 %)
EPS:	$-1.340

FY	2023
Omsetning:	$0
Bruttogevinst:	$-39 000.00 (0.00 %)
EPS:	$-1.340

FY	2022
Omsetning:	$0
Bruttogevinst:	$-27 000.00 (0.00 %)
EPS:	$-4.09

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.386

Financial Reports:

No articles found.

Elevation Oncology, Inc.

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.